Popular / View All Posts

Journal of Drugs in Dermatology JDD featuring Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study

Biopsy Type and Metastatic Recurrence in Melanoma: A Cohort Study

| Featured Articles, Latest News, Oncodermatology, Skin Cancer | No Comments
Surgical Resection Margins in Metastastic Melanoma: New Clinical Insights  This is a must-read article from JDD for clinicians evaluating surgical management strategies in cutaneous oncology. Cutaneous melanoma continues to account...
Journal of Drugs in Dermatology JDD featuring Biologics and Small-Molecule Inhibitors for the Treatment of Nummular Eczema: A Systematic Review

Biologics and Small-Molecule Inhibitors for the Treatment of Nummular Eczema: A Systematic Review

| Featured Articles, Latest News | No Comments
Target Modern Therapies for Nummular Eczema: What the Evidence Shows  Have you read this article from the JDD? Managing nummular eczema in clinical practice remains a persistent hurdle due to...
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden.

JDD Re:View With Dr. Beer

| Atopic Dermatitis, Featured Articles, JDD Re:View, Latest News, Medical Derm | No Comments
Navigating Atopic Dermatitis: Pathophysiology, Targeted Therapeutics, and Patient Perspectives Atopic dermatitis is one of the most commonly treated conditions in dermatology. While previous treatments revolved around optimizing sensitive skincare regimens...
Journal of Drugs in Dermatology JDD featuring Red Light Therapy in Cosmetic Dermatology: Marketing Claims Backed by Evidence?

Red Light Therapy in Cosmetic Dermatology: Marketing Claims Backed by Evidence?

| Aesthetics, Featured Articles, Lasers & Light Devices, Latest News | No Comments
Red Light Therapy in Modern Aesthetics: Bridging Evidence and Commercial Claims Are you up to date on the latest research from the JDD  regarding photobiomodulation? As direct-to-consumer wellness devices continue...